Back to Market Feed

Product Information

IBSRELA 50 MG TABLET is a brand product labeled by Ardelyx, Inc., priced at $32.5519 per EA under NDC 73154005060. Its NADAC has been published 179 times since Mar 22, 2023.

FDA first approved this application on Sep 12, 2019.

IBSRELA 50 MG TABLET

tenapanor hydrochloride
$32.5519per EA

Strength

53.2 mg/1

Manufacturer

Ardelyx, Inc.

NDC

73154005060

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TENAPANOR HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA211801

FDA Approved

9/12/2019

On Market Since

9/12/2019

Pharmacological Classes

Organic Anion Transporting Polypeptide 2B1 Inhibitors
Sodium-Hydrogen Exchanger 3 Inhibitor
Sodium-Hydrogen Exchanger 3 Inhibitors

Price Statistics

The NADAC for IBSRELA 50 MG TABLET has been published 179 times since Mar 22, 2023, and over the history we have for it it has risen 20.0%. The table below summarizes its recorded NADAC range and movement.

Current price$32.5519 per EA
All-time high$32.5863 (May 13, 2026)
All-time low$27.1191 (Mar 22, 2023)
52-week high$32.5863
52-week low$29.8890
Median price$28.6112
Average price$29.3530
Largest weekly change+9.0% (Jan 14, 2026)
Weeks tracked179
Tracking sinceMar 22, 2023

Price History

1W

-0.1%

1M

-0.1%

3M

-0.0%

6M

-0.1%

1Y

+8.8%

3Y

+20.0%

5Y

N/A

All

+20.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tenapanor hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

VOSEVI 400-100-100 MG TABLET
Brand
61958240101•Gilead Sciences, Inc.
$858.6884
per EA
EPCLUSA 400 MG-100 MG TABLET
Brand
61958220101•Gilead Sciences, Inc.
$866.3988
per EA

Frequently asked questions

What is the NADAC price of IBSRELA 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBSRELA 50 MG TABLET, manufactured by Ardelyx, Inc., is $32.5519 per EA (NDC 73154005060), effective Aug 19, 2026.

How has the price of IBSRELA 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBSRELA 50 MG TABLET has risen 20.0%. It has been tracked across 179 weekly CMS publications since Mar 22, 2023.

What are the highest and lowest recorded NADAC prices for IBSRELA 50 MG TABLET?

Since Mar 22, 2023, the NADAC for IBSRELA 50 MG TABLET has ranged from a low of $27.1191 (Mar 22, 2023) to a high of $32.5863 (May 13, 2026), with a median of $28.6112 per EA.

Are there cheaper alternatives to IBSRELA 50 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of IBSRELA 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures IBSRELA 50 MG TABLET?

IBSRELA 50 MG TABLET (NDC 73154005060) is labeled by Ardelyx, Inc., and CMS classifies it as a brand product.